LANGUAGE
KOREANENGLISH
LOCATION
  • COMPANY
  • R&D
    • R&D Institute
    • GMP Center
    • Clinical Development Status
    • Publications
  • PRODUCTS
    • 1st Generation
      • Overview
      • CARTISTEM®
      • PNEUMOSTEM®
    • 2nd Generation
      • Overview
      • SMUP-IA-01
      • SMUP-IV-01
    • R&D Inquiries
  • BUSINESS
    • CDMO
      • CDMO Service
      • Core Value
      • Manufacturing
      • Global CDMO
      • CDMO Inquiries
    • CELLTREE Cord Blood Bank
    • MOVITA Nutritional Supplements
    • LUCATREE Advanced Regenerative Medicine
  • IR
    • Stock Information
    • Disclosure
    • Financial Information
    • IR Inquiries
  • PR
    • MEDIPOST on Media
    • Corporate Brochure
  • CONTACT US
    • Customer Center
    • R&D Inquiries
    • CDMO Inquiries
    • IR Inquiries

Russian Representatives of the Korea-Russia Healthcare Cooperation Group Visit MEDIPOST

2017/07/26
CORD BLOOD BANK

Russian representatives of the Korea-Russia Healthcare Cooperation Group comprised for Russian healthcare professionals visited MEDIPOST’s headquarters at Pangyo, Gyeonggi-do on July 26.

This visit was arranged as part of the ‘2017 Korea-Russia Healthcare Cooperation Training Project’ organized by the Ministry of Health and Welfare and Korea Health Industry Development Institute.

Around 20 Russian representatives visited MEDIPOST’s cord blood processing and storage facilities as well as stem cell museum and talked with the staff of MEDIPOST.

For this project held from July 24 to September 15, the Russian representatives will visit major healthcare facilities in Korea. MEDIPOST is the only bio company the Russian representatives are visiting this time.

VIEW LIST

Related News

news 200518
Star Actress Choi Jiwoo Stores Her Baby’s Umbilical Cord Blo…
2020/05/18
news 180108
Longer-Term Storage of Cord Blood Gains Popularity Over 20,0…
2020/04/29

Latest News

knee img
MEDIPOST Inc. Treats First U.S. Participant in Phase III Tri…
2026/07/07
cdmo img33
MEDIPOST Secures FDA Agreement on Single Pivotal Phase 3 Stu…
2026/06/04
news
MEDIPOST’s CARTISTEM® Meets All Primary and Secondary…
2026/05/13
medipost img 2
MEDIPOST, INC. ANNOUNCES $140 MILLION IN FUNDING TO ACCELERA…
2026/01/09
knee img
MEDIPOST Inc. Treats First U.S. Participant in Phase III Tri…
2026/07/07
cdmo img33
MEDIPOST Secures FDA Agreement on Single Pivotal Phase 3 Stu…
2026/06/04
news
MEDIPOST’s CARTISTEM® Meets All Primary and Secondary…
2026/05/13
medipost img 2
MEDIPOST, INC. ANNOUNCES $140 MILLION IN FUNDING TO ACCELERA…
2026/01/09

Contacts

21, Daewangpangyo-ro 644, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea MEDIPOST Co., Ltd.
TEL : 82-2-3465-6677

Latest News

MEDIPOST Inc. Treats First U.S. Particip…2026.07.07
MEDIPOST Secures FDA Agreement on Single…2026.06.04
MEDIPOST’s CARTISTEM® Meets All Pr…2026.05.13
MEDIPOST, INC. ANNOUNCES $140 MILLION IN…2026.01.09
MEDIPOST Announces the Exclusive Commerc…2025.12.19

Family Site

· CELLTREE Cord Blood Bank
· MOVITA Nutritional Supplements

· LOCATION
· PRIVACY POLICY

©Copyright – The Future of Biotechnology, MEDIPOST